This post was originally published on this site
For Q1, Humana reported EPS of $9.38 on revenue of $26.74 billion, beating the average analyst estimate for earnings of $9.29 on revenue of $26.41B. Overall, sales rose 12% year-over-year.
“We’ve had a strong start to the year, with our outperformance underpinned by strong membership growth and favorable inpatient utilization trends in our individual Medicare Advantage business,” said Bruce D. Broussard, Humana’s president and chief executive officer.
Broussard also said that the strength of Humana’s business allowed the management to raise the FY adjusted EPS guidance to “at least” $28.25 from the prior forecast of “at least” $28.00. Analysts were expecting a full-year profit of $28.08 per share.
